XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings/Accumulated Deficit
Retained Earnings/Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2020 $ 1,680   $ 4 $ 8,517   $ (1,403)   $ (5,232) $ (206)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income (82)         (82)      
Other comprehensive income (loss) 3               3
Equity-based awards activity, net [1] (5)     (5)          
Issuance of common stock 1     1          
Common stock dividends and dividend equivalents declared [2] (80)         (80)      
Ending balance at Mar. 31, 2021 1,517   4 8,513   (1,565)   (5,232) (203)
Beginning balance at Dec. 31, 2020 1,680   4 8,517   (1,403)   (5,232) (206)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income 2,614                
Other comprehensive income (loss) 14                
Ending balance at Sep. 30, 2021 4,078   4 8,525   971   (5,230) (192)
Beginning balance at Mar. 31, 2021 1,517   4 8,513   (1,565)   (5,232) (203)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income 1,078         1,078      
Other comprehensive income (loss) 21               21
Shares reissuance for ESPP 2             2  
Equity-based awards activity, net 6     6          
Common stock dividends and dividend equivalents declared (80)         (80)      
Ending balance at Jun. 30, 2021 2,544   4 8,519   (567)   (5,230) (182)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income 1,618         1,618      
Other comprehensive income (loss) (10)               (10)
Equity-based awards activity, net 6     6          
Common stock dividends and dividend equivalents declared (80)         (80)      
Ending balance at Sep. 30, 2021 4,078   4 8,525   971   (5,230) (192)
Beginning balance at Dec. 31, 2021 3,600 $ (43) 4 8,531 $ (100) 464 $ 57 (5,273) (126)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income 1,736         1,736      
Other comprehensive income (loss) 8               8
Share repurchases (187)             (187)  
Equity-based awards activity, net [1] 2     2          
Common stock dividends and dividend equivalents declared [2] (86)         (86)      
Ending balance at Mar. 31, 2022 5,030   4 8,433   2,171   (5,460) (118)
Beginning balance at Dec. 31, 2021 3,600 $ (43) 4 8,531 $ (100) 464 $ 57 (5,273) (126)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income 2,316                
Other comprehensive income (loss) (28)                
Ending balance at Sep. 30, 2022 5,130   4 8,450   2,584   (5,754) (154)
Beginning balance at Mar. 31, 2022 5,030   4 8,433   2,171   (5,460) (118)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income 513         513      
Other comprehensive income (loss) $ (2)               (2)
Shares reissuance for ESPP (in shares) 1                
Shares reissuance for ESPP $ 3             2  
Share repurchases (168)             (168)  
Equity-based awards activity, net 8     8          
Common stock dividends and dividend equivalents declared (84)         (84)      
Ending balance at Jun. 30, 2022 5,300   4 8,442   2,600   (5,626) (120)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income 67         67      
Other comprehensive income (loss) (34)               (34)
Share repurchases (128)             (128)  
Equity-based awards activity, net 8     8          
Common stock dividends and dividend equivalents declared (83)         (83)      
Ending balance at Sep. 30, 2022 $ 5,130   $ 4 $ 8,450   $ 2,584   $ (5,754) $ (154)
[1] Includes $(6) million and $(9) million of equivalent shares purchased in lieu of tax withholding on equity compensation issuances for the quarters ended March 31, 2022 and 2021, respectively
[2] Dividends per common share were $0.35 for the quarters ended September 30, June 30 and March 31, 2022 and $0.325 for the quarters ended September 30, June 30 and March 31, 2021